Briacell Therapeutics Corp Cash Flow Reinvestment Rate
Briacell Therapeutics Corp cash flow reinvestment rate. Briacell Therapeutics Corp (BCTX) has a Cash Flow Reinvestment Rate of 0.00x as of April 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $22.57K. Explore Briacell Therapeutics Corp cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Briacell Therapeutics Corp (2006–2006)
Cash flow reinvestment rate of Briacell Therapeutics Corp from 2006 to 2006. Historical reinvestment intensity for Briacell Therapeutics Corp across 1 annual periods. Explore BCTX capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Briacell Therapeutics Corp Cash Flow Reinvestment Rate by Year (2006–2006)
Briacell Therapeutics Corp cash flow reinvestment rate by year from 2006 to 2006. Year-by-year capital reinvestment analysis for Briacell Therapeutics Corp. For the full cash flow conversion analysis, see cash flow conversion of Briacell Therapeutics Corp.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2006 | 0.00x | $0.00 | $1.13K | $0.00 | — |